Selective Estrogen Receptor Modulator Delivery of Quinone Warheads to DNA Triggering Apoptosis in Breast Cancer Cells
- 16 November 2009
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 4 (12) , 1039-1049
Abstract
Estrogen exposure is a risk factor for breast cancer, and estrogen oxidative metabolites have been implicated in chemical carcinogenesis. Oxidation of the catechol metabolite of estrone (4-OHE) and the beta-naphthohydroquinone metabolite of equilenin (4-OHEN) gives o-quinones that produce ROS and damage DNA by adduction and oxidation. To differentiate hormonal and chemical carcinogensis pathways in estrogen receptor positive ER(+) cells, catechol or beta-naphthohydroquinone warheads were conjugated to the selective estrogen receptor modulator (SERM) desmethylarzoxifene (DMA). ER binding was retained in the DMA conjugates; both were antiestrogens with submicromolar potency in mammary and endometrial cells. Cytotoxicity, apoptosis, and caspase-3/7 activation were compared in ER(+) and ER(-)MDA-MB-231 cells, and production of ROS was detected using a fluorescent reporter. Comparison was made to DMA, isolated warheads, and a DMA-mustard. Conjugation of warheads to DMA increased cytotoxicity accompanied by induction of apoptosis and activation of caspase-3/7. Activation of caspase-3/7, induction of apoptosis, and cytotoxicity were all increased significantly in ER(+) cells for the DMA conjugates. ROS production was localized in the nucleus for conjugates in ER(+) cells. Observations are compatible with beta-naphthohydroquinone and catechol groups being concentrated in the nucleus by ER binding, where oxidation and ROS production result, concomitant with caspase-dependent apoptosis. The results suggest that DNA damage induced by catechol estrogen metabolites can be amplified in ER(+) cells independent of hormonal activity. The novel conjugation of quinone warheads to an ER-targeting SERM gives ER-dependent, enhanced apoptosis in mammary cancer cells of potential application in cancer therapy.Keywords
This publication has 45 references indexed in Scilit:
- Development of a Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry Method for Analysis of Stable 4-Hydroxyequilenin−DNA Adducts in Human Breast Cancer CellsChemical Research in Toxicology, 2009
- Comparative Methods for Analysis of Protein Covalent Modification by Electrophilic Quinoids Formed from XenobioticsBioconjugate Chemistry, 2009
- Estrogen Receptor α Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the NucleusJournal of Biological Chemistry, 2009
- A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptorJournal of Inorganic Biochemistry, 2009
- Aminoflavone induces oxidative DNA damage and reactive oxidative species‐mediated apoptosis in breast cancer cellsInternational Journal of Cancer, 2008
- Potential Mechanisms of Estrogen Quinone CarcinogenesisChemical Research in Toxicology, 2007
- Uterine Peroxidase-Catalyzed Formation of Diquinone Methides from the Selective Estrogen Receptor Modulators Raloxifene and Desmethylated ArzoxifeneChemical Research in Toxicology, 2007
- Chemical Modification Modulates Estrogenic Activity, Oxidative Reactivity, and Metabolic Stability in 4‘F-DMA, a New Benzothiophene Selective Estrogen Receptor ModulatorChemical Research in Toxicology, 2006
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002